Recipharm has made a mandatory offer for the outstanding shares in Cobra Biomanufacturing following its acquisition of 43.87% of the company for £437,625. The offer values Cobra at almost £1m. Cobra has said it expects Recipharm to make a loan to Cobra so it can meet its working capital requirements during the integration of the two businesses. Cobra had announced it was in sales talks last month.
Proactive Investors
InvestEgate
Wednesday 16 December 2009
Recipharm to acquire Cobra
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment